Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.49M | 26.49M | 24.05M | 21.60M | 23.31M |
| Total Receivables | -- | 3.00M | 184.00K | 229.00K | 200.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 205.00K | 305.00K | 94.00K | 277.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | 29.69M | 24.54M | 21.92M | 23.79M |
|
|
|||||
| Total Current Assets | -- | 29.69M | 24.54M | 21.92M | 23.79M |
| Net Property, Plant & Equipment | -- | 36.00K | 70.00K | 106.00K | 132.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 52.00K | 52.00K | 85.00K | 85.00K |
| Total Assets | -- | 29.78M | 24.66M | 29.32M | 32.88M |
|
|
|||||
| Total Accounts Payable | -- | -- | 21.00K | 385.00K | 366.00K |
| Total Accrued Expenses | -- | 530.00K | 799.00K | 5.98M | 8.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 125.00K | 295.00K | 5.73M | 5.50M |
| Total Other Current Liabilities | -- | 125.00K | 295.00K | 5.73M | 5.50M |
| Total Current Liabilities | -- | 655.00K | 1.12M | 12.10M | 14.03M |
|
|
|||||
| Total Current Liabilities | -- | 655.00K | 1.12M | 12.10M | 14.03M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 9.17M | 10.54M |
| Total Liabilities | -- | 655.00K | 1.12M | 21.27M | 24.57M |
|
|
|||||
| Common Stock & APIC | -- | 145.87M | 145.77M | 145.74M | 145.62M |
| Retained Earnings | -- | -117.06M | -122.47M | -136.62M | -136.19M |
| Treasury Stock & Other | -- | 70.00K | -- | -1.31M | -1.36M |
| Total Common Equity | 28.88M | 28.88M | 23.30M | 7.80M | 8.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 247.00K | 247.00K | 247.00K | 247.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 247.00K | 247.00K | 247.00K | 247.00K | 247.00K |
|
|
|||||
| Total Common Equity | 28.88M | 28.88M | 23.30M | 7.80M | 8.06M |
| Total Preferred Equity | 247.00K | 247.00K | 247.00K | 247.00K | 247.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 29.13M | 29.13M | 23.55M | 8.05M | 8.31M |
|
|
|||||